Antimicrobial resistance in Neisseria gonorrhoeae and co-infections (Vienna, Austria; 2015-2024) [0.03%]
淋病奈瑟菌的抗菌药物耐药性及合并感染(奥地利维也纳；2015-2024年)
Ursula Fürnkranz,Maria Haller,Katharina Schwarz et al.
Ursula Fürnkranz et al.
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study [0.03%]
利替菲拉布在皮肤型狼疮患者中对皮肤病疗效的II期LILAC研究
Victoria P Werth,Joseph F Merola,Richard Furie et al.
Victoria P Werth et al.
Background: Cutaneous lupus erythematosus (CLE) has no approved targeted therapies. In Part B of the randomized, double-blind, placebo-controlled, Phase 2 LILAC study, litifilimab demonstrated a dose-response relationship...
Updated guidelines on hepatitis B virus infection management in patients treated with systemic immunomodulatory agents [0.03%]
免疫抑制剂治疗患者乙型肝炎管理的新指南
Laura Mateu-Arrom,Adolfo Gallego Moya,Lluis Puig
Laura Mateu-Arrom
Pregnancy-associated melanoma: A distinct entity requiring vigilance [0.03%]
妊娠相关的黑色素瘤：一个需要警惕的特殊实体肿瘤
Maria Kostaki,Michaela Plaka,Vasiliki Chardalia et al.
Maria Kostaki et al.
Personalized care for older skin cancer patients: Impact of frailty screening on treatment decisions [0.03%]
脆弱性评估对老年皮肤癌患者治疗决策个性化的影响
Esther Groll,Zsanna Hetényi,Ella Kokkola et al.
Esther Groll et al.
Balanoposthitis due to Klebsiella aerogenes in men who have sex with men [0.03%]
由阴沟肠杆菌引起的男性同性性行为者的包皮龟头炎
Romain Salle,Gentiane Monsel,Sébastien Fouéré et al.
Romain Salle et al.
Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access program [0.03%]
dupilumab治疗中重度结节性痒疹：早期用药计划的实效数据研究
Marie Jachiet,Clémentine Toussaint,Valérie Dorizy-Vuong et al.
Marie Jachiet et al.
Family quality-of-life burden in chronic spontaneous urticaria: A multicentre study [0.03%]
慢性自发性荨麻疹的家庭生活质量负担：一项多中心研究
Beatrice Martinez Zugaib Abdalla,Roberta Fachini Jardim Criado,Kanokvalai Kulthanan et al.
Beatrice Martinez Zugaib Abdalla et al.
Background: Chronic spontaneous urticaria (CSU) can cause psychosocial and quality of life burden on patients and their family members and caregivers. Despite its recognition as a debilitating disease, limited data exist ...